What Ebb Therapeutics does

Ebb Therapeutics is a privately held medical device company founded in 2008 and headquartered in Pittsburgh, Pennsylvania. Per its firmographic profile, the company develops a regional cerebral thermal therapy (RCTT) device intended for use in insomnia and sleep disorders — a non-pharmacological, device-based intervention targeting the sleep medicine market.

In January 2017, Ebb Therapeutics closed a $38 million Series 2 financing round led by Kohlberg Kravis Roberts & Co., with participation from Arboretum Ventures, Partner Ventures, and Versant Ventures, signaling institutional validation of the thermal-sleep therapeutic thesis. Kevin Wasserstein serves as Chairman of the Board. The current operating footprint is reported at 1–10 employees, and the company maintains a consumer-facing web presence at ebbsleep.com.

A material data caveat applies to this profile: the source material aggregated for analysis is dominated by Sleepme / Sleep Solutions Inc. content covering the Chilipad consumer temperature-controlled sleep ecosystem (Chilipad Dock Pro, Chilipad Cube, Chilipad 2.0, OOLER, Sleep Tracker, Mobile App, and Developer API). The input explicitly flags that ownership and operational linkage between Ebb Therapeutics and Sleepme/Sleep Solutions Inc. could not be confirmed from available sources. As a result, this description treats Ebb Therapeutics as the medical-device entity described in firmographics and reserves Sleepme/Chilipad product data for context only. Revenue model, pricing, and detailed go-to-market mechanics for Ebb Therapeutics specifically are not established in the input.

Name

Ebb Therapeutics

Website

https://ebbsleep.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Ebb Therapeutics is a privately held Pittsburgh-based medical device company founded in 2008 that develops a regional cerebral thermal therapy (RCTT) device for insomnia and sleep disorders. It raised $38M in 2017 led by KKR.

Ownership category

akta.pro rank

Product category

Sleep Therapy Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industry

Sleep, Stress & Mood Support (HLAIADAG)

Keywords

• Sleep therapy devices
• Insomnia treatment devices
• Cerebral thermal therapy
• Neuromodulation devices
• Sleep medicine devices

Headquarters

HQ city

Pittsburgh

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales

Core offering

Ebb Therapeutics develops a Regional Cerebral Thermal Therapy (RCTT) device for use in the treatment of insomnia and sleep disorders. The product is a hardware medical device designed to deliver targeted thermal therapy to the brain's frontal cortex as a non-pharmacological intervention for sleep disorders.

Product overview

Sleepme (Sleep Solutions Inc.) offers a unified temperature-controlled sleep ecosystem centered around the Chilipad product line. The core offerings include the Chilipad Dock Pro, Chilipad Cube, Chilipad 2.0, and OOLER systems, which provide water-based temperature regulation for mattresses. The ecosystem is complemented by the Sleep Tracker device and Sleepme Mobile App for personalized temperature control and sleep monitoring. Accessories include the Chilipad Mattress Protector. All products are managed through a central platform with Developer API access for integrations.

Differentiator

Problem solved

Functional benefit

Products and services

• Regional Cerebral Thermal Therapy (RCTT) Device

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Recent moves5 records

Expansion highlights4 records

Direct peers

• Big Health (Sleepio): Big Health's Sleepio is an FDA-authorized digital therapeutic for insomnia, directly competing with Ebb Therapeutics for the non-pharmacologic insomnia treatment category, though via a software-only delivery model rather than a hardware device.
• Fisher Wallace Laboratories: Fisher Wallace manufactures a consumer/prescription wearable brain stimulation device for insomnia, anxiety, and depression — a direct neuromodulatory-device peer targeting the same sleep-disorder therapeutic space as Ebb's RCTT.
• Cereve (now part of J&J / Sleeptech asset): Cereve historically developed a sleep-surface thermal device for insomnia — closely comparable in modality (cerebral/head cooling during sleep) to Ebb's RCTT and a useful historical analog for commercialization and regulatory trajectory.

Broad incumbents

• Eight Sleep: Eight Sleep sells consumer-grade temperature-controlled mattress systems (Pod) for sleep optimization. It is a broad incumbent in temperature-regulated sleep with far greater scale and brand recognition than Ebb, though positioned in consumer rather than clinical channels.
• Oura: Oura's smart ring is one of the leading consumer sleep and recovery wearables. While not a therapeutic, Oura represents the broad incumbent in sleep tracking that frames consumer expectations for sleep technology adjacent to Ebb's clinical positioning.
• Whoop: Whoop's wearable platform includes sleep tracking, recovery scoring, and strain management, positioning it as a broad incumbent in the sleep and recovery category where Ebb's therapeutic device must compete for consumer and clinical mindshare.

Emerging players

• Dreem: Dreem develops a sleep wearable headband with EEG tracking and behavioral sleep coaching — comparable to Ebb as a technology-driven sleep therapy play, though focused on monitoring and behavioral intervention rather than thermal neuromodulation.
• Elemind Technologies: Elemind is developing non-invasive neuromodulation (acoustic and electrical stimulation) for sleep, focus, and relaxation — comparable to Ebb as an emerging neurotech sleep therapy company targeting similar mechanism-of-action-adjacent indications.

Regional players

• Sleepme (Sleep Solutions Inc.): Sleepme markets the Chilipad/OOLER consumer water-based temperature-controlled sleep systems. While a consumer product rather than a medical device, Sleepme is a comparable temperature-modulated sleep player that is frequently confused with Ebb in data sources due to product adjacency.
• Hatch (Restorative Health): Hatch sells consumer sleep products (Restore smart sunrise alarm, sound machines) and is adjacent to Ebb's sleep therapy focus; while not a clinical competitor, Hatch competes for consumer attention and shelf space in the broader sleep-wellness category.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/ebbsleep
• Facebookfacebook.com/ebbsleep

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ebb Therapeutics